XURXO
GARCIA OTERO
Investigador contratado posdoutoral
Publicacións (31) Publicacións de XURXO GARCIA OTERO
2026
-
Design and characterization of intravitreal bevacizumab-loaded PLGA nanoparticles: pharmacokinetic and biodistribution impact
Drug Delivery and Translational Research, Vol. 16, Núm. 4, pp. 1262-1284
-
Intravitreal faricimab pharmacokinetics assessed by PET imaging in a neovascular Age-related Macular Degeneration rat model
International Journal of Pharmaceutics: X, Vol. 11
-
Nanoassemblies for oral protein delivery — The case of monoclonals for inflammatory bowel disease
Journal of Controlled Release, Vol. 389
2025
-
A physiologically based pharmacokinetic model to describe [89Zr]Zr-DFO-Adalimumab specific activity after intravitreal administration to rats with endotoxin-induced uveitis
International Journal of Pharmaceutics, Vol. 681
-
Intravitreal Administration of Adalimumab-Loaded Poly(Lactic-co-Glycolic Acid) Nanoparticles: Effects on Biodistribution and Pharmacokinetics
Small Science
-
Long acting injectables & implants: advances in intraocular drug delivery
International Journal of Pharmaceutics, Vol. 683
-
PET biodistribution study of subcutaneous and intravenous administration of adalimumab in an inflammatory bowel disease model
International Journal of Pharmaceutics, Vol. 669
2024
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
-
Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study
International Journal of Molecular Sciences, Vol. 25, Núm. 18
-
Formulation strategies to improve the bioavailability of poorly absorbed drugs
Dosage Forms, Formulation Developments and Regulations: Recent and Future Trends in Pharmaceutics, Volume 1, pp. 223-255
-
Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics
International Journal of Pharmaceutics, Vol. 662
2023
-
Antifungal Combination Eye Drops for Fungal Keratitis Treatment
Pharmaceutics, Vol. 15, Núm. 1
-
Compression pressure-induced synergy in xanthan and locust bean gum hydrogels. Effect in drug delivery
Journal of Drug Delivery Science and Technology, Vol. 89
-
Estudio farmacocinético de adalimumab intravítreo en un modelo de rata con uveítis mediante PET
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
2022
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
Pharmaceutics, Vol. 14, Núm. 10
-
Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 172, pp. 144-156
-
Mucoadhesive PLGA Nanospheres and Nanocapsules for Lactoferrin Controlled Ocular Delivery
Pharmaceutics, Vol. 14, Núm. 4
-
PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model
International Journal of Pharmaceutics, Vol. 627
2021
-
Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model
Pharmaceutics, Vol. 13, Núm. 10
-
Base preclínica de sistemas lipídicos nanoestructurados (NLC) cargados con bevacizumab: diseño, desarrollo y caracterización fisicoquímica
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 87-89